Summary & Overview
HCPCS J0696: Injection, ceftriaxone sodium, per 250 mg
HCPCS Level II code J0696 denotes injection of ceftriaxone sodium, billed per 250 mg. As a commonly used third-generation cephalosporin, ceftriaxone is administered parenterally for a range of bacterial infections, making this code nationally relevant for acute care, outpatient infusion, emergency, and clinic-based treatment settings. Accurate use of J0696 affects drug cost reporting, reimbursement for parenteral therapy, and inventory tracking at facilities that provide injectable antibiotics.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find practical benchmarking on utilization and reimbursement patterns, clarification of billing considerations for parenteral antibiotic products, and clinical context about typical administration settings. The publication outlines common policy updates that influence coverage and payment for injectable antimicrobials and highlights factors that drive variation in billed units and site-of-service costs.
This resource is intended for billing managers, revenue cycle staff, clinical administrators, and policy analysts who require a concise reference on billing and policy implications tied to parenteral ceftriaxone dosing and claims reporting.
Billing Code Overview
HCPCS Level II code J0696 represents an injectable formulation of ceftriaxone sodium, billed per 250 mg unit. This code is used to report the drug product administered to a patient as part of antimicrobial therapy.
-
Service type: Drug administration (intravenous or intramuscular antibiotic injection)
-
Typical site of service: Hospital outpatient departments, physician offices, clinic infusion centers, emergency departments, and other settings where parenteral antibiotics are administered
Clinical & Coding Specifications
Clinical Context
A 68-year-old male presents to an outpatient infusion center with a diagnosis of acute complicated urinary tract infection requiring parenteral antibiotics. The clinician orders intravenous ceftriaxone for empiric coverage pending culture results. The typical clinical workflow includes medication order entry, verification by pharmacy, preparation of J0696 (injection, ceftriaxone sodium, per 250 mg) reconstituted to the ordered dose, administration via intramuscular or intravenous push/infusion by a registered nurse, vital-sign monitoring during and after administration, and documentation of lot number and expiration for medication traceability. Billing is generated for the vial units administered using J0696, with appropriate modifiers appended when applicable (for example, modifier 59 to indicate a distinct procedural service if another injectable was administered on the same day). Typical sites of service include outpatient infusion centers, hospital inpatient units, emergency departments, and ambulatory surgical centers when ceftriaxone is used perioperatively for surgical prophylaxis. The typical patient scenario also includes pre-existing allergies screened (notably beta-lactam allergy), renal and hepatic function review for dosing considerations, and microbiology follow-up to tailor therapy.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|